(Reuters) - President Donald Trump on Monday said he will undergo his annual physical examination on Friday at Walter Reed ...

Asian markets plunged on Monday after Donald Trump warned foreign governments they would have to pay “a lot of money” to lift ...

Citi analyst Patrick Donnelly lowered the firm’s price target on Icon (ICLR) to $215 from $290 and keeps a Buy rating on the shares as part of a ...

Create a lasting legacy for your business with these platforms, firms and worthwhile causes Looking for ways to keep your ...

Battery electric might very well be the way of the future, but the oldest fleet trucks in the U.S. would be wise to look into ...

Using blockchain technology to support real-world infrastructure, DePIN creates tangible value and generates real revenue, ...

Year after year, funds actively managed by professional analysts fail to outperform passive index funds. So how are ...

LVS Advisory, a New York City-based full-service investment firm, recently released its first-quarter 2025 investor letter. A ...

We purchased shares of Icon in March 2024 for ~$323.00 per share. Why did we sell our ICLR position and move on? Click here ...

Dental hygienist Roberta Brito, left, discusses dental hygiene with patient Frank Mandrack, right, at Inner City Health ...

Justin Vogel, the chief financial officer at Tolerance Bio, which raised more than $20 million in a seed round of financing ...

A webcast replay of the conference call will be available approximately one hour following the conclusion of the call. ICON plc is a world-leading clinical research organisation powered by healthcare ...